Pherecydes Pharma and BIOASTER join forces in the treatment of bacteremia

“BIOASTER is thrilled  to bring its expertise, its resources and its technology innovations to contribute to the success of a challenging and promising research program of Pherecydes, a Pharma French biotech. Through this program, we are proud to join the fight against antimicrobial resistance though the use of phages.” Dr. Nathalie GARCON, CSO BIOASTER

Download the Press Release (French version only) HERE.